Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids.
H. Asou
, W. Verbeek
,
E. Williamson
, E. Elstner
, T. Kubota
, N. Kamada
, H. P. Koeffler
Research output
:
Contribution to journal
›
Article
›
peer-review
75
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Growth inhibition of myeloid leukemia cells by troglitazone, a ligand for peroxisome proliferator activated receptor gamma, and retinoids.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Troglitazone
100%
Myeloid
71%
Growth
57%
Peroxisome Proliferator-Activated Receptor Gamma
57%
Western Blot
28%
Adipocyte
28%
Nested Gene
14%
Cell Cycle
14%
DNA Binding
14%
Growth Inhibition
14%
G1 Phase
14%
Retinoid X Receptor Alpha
14%
Retinoic Acid Receptor
14%
Transcription
14%
Pharmacology, Toxicology and Pharmaceutical Science
Troglitazone
100%
Peroxisome Proliferator Activated Receptor Gamma
57%
Myeloid Leukemia
57%
Ligand
42%
Retinoid
28%
Receptor
14%
DNA
14%
Acute Myeloid Leukemia
14%
Antidiabetic Agent
14%
Cell Cycle
14%
Retinoid X Receptor Alpha
14%
Retinoic Acid Receptor
14%